Beginning in 2003, news stories charged that hundreds of National Institutes of Health scientists were engaged in ethically dubious practices, including consulting for or holding stock in companies whose products might benefit from NIH support. After internal and congressional probes of these potential conflicts of interest, NIH Director Elias A.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.